Jing Yang

Jing Yang

Auto-generated profile, based on publicly available information

Jing Yang

Chengdu, China)

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
PHPingsheng Huang
Pingsheng Huang
XWXiaoli Wang
Xiaoli Wang
XLXiaoyu Liang
Xiaoyu Liang
JYJing Yang
Jing Yang
CZChuangnian Zhang
Chuangnian Zhang
WWWei wei Wang
Wei wei Wang

1 October 2020 in Biomaterials
Verified
Journal Article
Closed access
JDJianwei Duan
Jianwei Duan
ZCZuoguan Chen
Zuoguan Chen
XLXiaoyu Liang
Xiaoyu Liang
YCYoulu Chen
Youlu Chen
HLHuiyang Li
Huiyang Li
JYJing Yang
Jing Yang

1 January 2021 in Bioactive Materials
Verified
Journal Article
Open access
ZCZuoguan Chen
Zuoguan Chen
JDJianwei Duan
Jianwei Duan
YDYongpeng Diao
Yongpeng Diao
YCYoulu Chen
Youlu Chen
XLXiaoyu Liang
Xiaoyu Liang
YLYongjun Li
Yongjun Li
The successful treatment of limb ischemia requires that promote angiogenesis along with microenvironment improvement. Zinc ions have been reported to stimulate angiogenesis, but application was limited to the toxicity concerns. We hypothesized that zinc based metal-EGCG capsule (EGCG/Zn Ps) can achieve sustained release Zn2+ resulting in reduced toxicity and improve angiogenesis as well as the improvement of microenvironment by ROS scavenging of EGCG. The surface morphology, zeta potential, infrared absorbance peaks and zinc ion release profile of the EGCG/Zn Ps were measured. In vitro, EGCG/Zn showed significantly antioxidant, anti-inflammatory and induced cell migration effect. In addition, EGCG/Zn Ps enabled the sustained release of zinc ions, which reduced cytotoxicity and enhanced the secretion of vascular endothelial growth factor (VEGF) in vitro and in vivo. In mouse models of limb ischemia, EGCG/Zn Ps promoted angiogenesis and cell proliferation in ischemic tissues. Moreover, EGCG/Zn Ps group exhibited the most significant recovery of limb ischemic score, limb temperature and blood flow than other groups. In conclusion, EGCG/Zn Ps is a safe and promising approach to combine the merit of Zn2+ and EGCG, thus enabling the direct application to limb ischemia.

23 January 2018 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
XWXiaoli Wang
Xiaoli Wang
XLXuanling Li
Xuanling Li
XLXiaoyu Liang
Xiaoyu Liang
JLJiayi Liang
Jiayi Liang
CZChao Zhang
Chao Zhang
HSHongfan Sun
Hongfan Sun
Reactive oxygen species (ROS)-responsive nanocapsules for cancer drug delivery were engineered from green tea polyphenol–metal networks. Briefly, DOX-doped ZIF-8 nanoparticles were synthesized via coprecipitation and coated with a layer of EGCG–Fe(III) complexes by suspending in EGCG and ferric chloride aqueous solutions under mild conditions. The DOX-encapsulating EGCG/Fe nanocapsules (DOX@EGCG/Fe NCs) with a diameter of 399 nm were obtained after template removal. The as-prepared EGCG/Fe NCs can reduce ROS potential accompanied by their degradation. Moreover, DOX@EGCG/Fe NCs can be quickly internalized by cancer cells, and then the intracellular drug release was greatly accelerated in response to overproduced ROS of tumor. Owing to higher ROS levels inside tumor cells compared with normal cells, DOX@EGCG/Fe NCs cause selective cytotoxicity for tumor cells over normal cells. Furthermore, the cytotoxicity of DOX@EGCG/Fe NCs was increased with the increasing incubation time with cancer cells, whereas the tendency of free DOX was reversed. Accordingly, DOX@EGCG/Fe NCs demonstrate good tumor growth inhibition (84.2%) with minor systemic toxicity, which would be a promising candidate for B16 melanoma therapy. Hopefully, our approach could be extended to many other delivery systems such as water soluble/insoluble drugs, gene and protein due to the diversity of polyphenol–metal networks and ZIF-8 templates.

12 March 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
XLXiaoyu Liang
Xiaoyu Liang
JDJianwei Duan
Jianwei Duan
XLXuanling Li
Xuanling Li
XZXiaowei Zhu
Xiaowei Zhu
YCYoulu Chen
Youlu Chen
JYJing Yang
Jing Yang
Subunit vaccines that are designed based on recombinant antigens or peptides have shown promising potential as viable substitutes for traditional vaccines due to their better safety and specificity. However, the induction of adequate in vivo immune responses with appropriate effectiveness remains a major challenge for vaccine development. More recently, the implementation of a nanoparticle-based antigen delivery system has been considered a promising approach to improve the in vivo efficacy for subunit vaccine development. Thus, we have designed and prepared a nanoparticle-based antigen delivery system composed of three-armed PLGA, which is conjugated to PEG via the peroxalate ester bond (3s-PLGA-PO-PEG) and PEI as a cationic adjuvant (PPO NPs). It is known that during a foreign pathogen attack, NADPH, an oxidase, of the host organism is activated and generates an elevated level of reactive oxygen species, hydrogen peroxide (H2O2) primarily, as a defensive mechanism. Considering the sensitivity of the peroxalate ester bond to H2O2 and the cationic property of PEI for the induction of immune responses, this 3s-PLGA-PO-PEG/PEI antigen delivery system is expected to be both ROS responsive and facilitative in antigen uptake without severe toxicity that has been reported with cationic adjuvants. Indeed, our results demonstrated excellent loading capacity and in vitro stability of the PPO NPs encapsulated with the model antigen, ovalbumin (OVA). Co-culturing of bone marrow dendritic cells with the PPO NPs also led to enhanced dendritic cell maturation, antigen uptake, enhanced lysosomal escape, antigen cross-presentation and in vitro CD8+ T cell activation. In vivo experiments using mice further revealed that the administration of the PPO nanovaccine induced robust OVA-specific antibody production, upregulation of splenic CD4+ and CD8+ T cell proportions as well as an increase in memory T cell generation. In summary, we report here a ROS-triggered nanoparticle-based antigen delivery system that could be employed to promote the in vivo efficacy of vaccine-induced immune responses.

15 February 2021 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
YRYing Ren
Ying Ren
HZHan Zhang
Han Zhang
YWYunping Wang
Yunping Wang
BDBo Du
Bo Du
JYJing Yang
Jing Yang
QZQiqing Zhang
Qiqing Zhang